Search research articles
Contact Us
Filters
Showing results (221-230 of 362) with videos related to
Page
of 37
Sort By:
Nature Medicine
|
March 30, 2026
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial
Scott D Solomon, John J V McMurray, G Michael Felker, et al.
JACC. Basic to Translational Science
|
December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Thorsten M Leucker, William O Osburn, Paula Reventun, et al.
European Heart Journal
|
October 30, 2013
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Natalie Bello, et al.
Journal of the American College of Cardiology
|
April 22, 2022
Association of Left Atrial Structure and Function With Heart Failure in Older Adults
Riccardo M Inciardi, Brian Claggett, Masatoshi Minamisawa, et al.
JAMA Cardiology
|
March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study
Masatoshi Minamisawa, Brian Claggett, David Adams, et al.
European Journal of Heart Failure
|
April 7, 2021
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF)
Tor Biering-Sørensen, Masatoshi Minamisawa, Jiankang Liu, et al.
The American Journal of Cardiology
|
January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)
Thao Huynh, Brian J Harty, Brian Claggett, et al.
The Lancet. Diabetes & Endocrinology
|
March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
Jelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.
JACC. Heart Failure
|
March 26, 2024
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
Thomas R Fleming, Janet Wittes, Mona Fiuzat, et al.
JACC. Heart Failure
|
September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)
Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Page
of 37
Search research articles
Search
Showing results (221-230 of 362) with videos related to
Sort By:
Page
of 37
Nature Medicine
|
March 30, 2026
The NPR1 agonist antibody XXB750 in heart failure: a phase 2 randomized trial
Scott D Solomon, John J V McMurray, G Michael Felker, et al.
JACC. Basic to Translational Science
|
December 14, 2021
Effect of Crizanlizumab, a P-Selectin Inhibitor, in COVID-19: A Placebo-Controlled, Randomized Trial
Thorsten M Leucker, William O Osburn, Paula Reventun, et al.
European Heart Journal
|
October 30, 2013
Left ventricular dyssynchrony in patients with heart failure and preserved ejection fraction
Angela B S Santos, Elisabeth Kraigher-Krainer, Natalie Bello, et al.
Journal of the American College of Cardiology
|
April 22, 2022
Association of Left Atrial Structure and Function With Heart Failure in Older Adults
Riccardo M Inciardi, Brian Claggett, Masatoshi Minamisawa, et al.
JAMA Cardiology
|
March 17, 2019
Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study
Masatoshi Minamisawa, Brian Claggett, David Adams, et al.
European Journal of Heart Failure
|
April 7, 2021
The effect of the cardiac myosin activator, omecamtiv mecarbil, on right ventricular structure and function in chronic systolic heart failure (COSMIC-HF)
Tor Biering-Sørensen, Masatoshi Minamisawa, Jiankang Liu, et al.
The American Journal of Cardiology
|
January 8, 2019
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)
Thao Huynh, Brian J Harty, Brian Claggett, et al.
The Lancet. Diabetes & Endocrinology
|
March 24, 2017
Effect of sacubitril/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial
Jelena P Seferovic, Brian Claggett, Sara B Seidelmann, et al.
JACC. Heart Failure
|
March 26, 2024
Training the Next Generation of Data Monitoring Committee Members: An Initiative of the Heart Failure Collaboratory
Thomas R Fleming, Janet Wittes, Mona Fiuzat, et al.
JACC. Heart Failure
|
September 8, 2014
Heart failure risk across the spectrum of ankle-brachial index: the ARIC study (Atherosclerosis Risk In Communities)
Deepak K Gupta, Hicham Skali, Brian Claggett, et al.
Page
of 37